Cardioprotective effect of ascorbic acid on doxorubicin-induced myocardial toxicity in rats

Indian Journal of Pharmacology

Volumn 43, Issue 5, 2011, Pages 507-511

  Viswanatha Swamy, A H M ^a   Wangikar, U ^a   Koti, B C ^a   Thippeswamy, A H M ^a   Ronad, P M ^a   Manjula, D V ^b  

^a KLE College of Pharmacy   (India)

^b Guttal Ayurvedic Medical Collge   (India)

Author keywords

Ascorbic acid; cardiotoxicity; doxorubicin; free radicals

Indexed keywords

ALANINE AMINOTRANSFERASE; ASCORBIC ACID; ASPARTATE AMINOTRANSFERASE; CATALASE; CREATINE KINASE; DOXORUBICIN; GLUTATHIONE; LACTATE DEHYDROGENASE; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CARDIOTOXICITY; CONTROLLED STUDY; FEMALE; HEART MUSCLE; HEART MUSCLE INJURY; HEART PROTECTION; HEART WEIGHT; HISTOPATHOLOGY; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; RAT;

EID: 80053348814     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.84952     Document Type: Article

References (30)

1. Singal PK, Segstro RJ, Singh RP, Kutryk MJ. Changes in lysosomal morphology and enzyme morphology and enzyme activities during the development of Adriamycin induced cardiomyopathy. Can J Cardiol 1985;1:139-47.
2. Bristow MR, Sageman WS, Scott RH, Billingham ME, Bowden RE, Kernoff RS, et al. Acute and chronic cardiovascular effect of doxorubicin in dog. J Cardiovasc Phamacol 1980;2:487-515.
3. nd, Ren J. Doxorubicin induces cardiomyocytes dysfunction via P38 MAP kinase dependant oxidative stress mechanism. Cancer Detect Prev 2005;29:294-9.
4. Hanna HA, Fatima M, Gamal AE, Senot HD. Cardioprotective activities on doxorubicin induced cardiotoxicity. Bioorg Med Chem 2005;13:1847-57.
5. Premkumar K, Bowlus CL. Ascorbic acid does not increase the oxidative stress induced by dietary iron in C3H mice. J Nutr 2004;134:435-8.
6. Lou AS, Broun, Frank LH, Dean PJ. Ascorbic deficiency and oxidative stress in alveolar type II cell. Am J Physiol Lung Cell Mol Physiol 1997;273:782-8.
7. Ayaz SA, Bhandari K, Pillai K. Influence of DL and a lipoic acid and Vitamin E against doxorubicin induced biochemical and histological changes in cardiac tissue of rat. Indian J Pharmacol 2005;37:294-9.
8. Rosalki SB. An improved procedure for serum creatine phosphokinase determination. J Lab Clin Med 1967;69:696-705.
9. Henry RJ, Chiamori N, Goiub OJ, Berkman S. Revised spectrophotometric methods for the determination of glutamic-oxalacetic transaminase, glutamic-pyruvic transaminase and lactic acid dehydrogenase. Am J Clin Path 1960;34:381-98.
10. Sarter B. Coenzyme Q10 and Cardiovascular disease: A review. J Cardiovasc Nurs 2002;16:9-20.
11. Bradley DW, Maynard JE, Emery G. Comparison of ascorbic acid concentrations in whole blood obtained by venipuncture or by finger prick. Clin Chem 1972;18:968-70.
12. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys1959;82:70-7.
13. Mishra HP, Fridovich I. The role of superoxide anion in the auto-oxidation of Epinephrine and a simple assay for superoxide dismuatse. J Biol Chem 1972;247:3170-5.
14. Claiborne A. Catalase activity. In: Greenwald RA (editor). CRC Handbook of Methods for Oxygen Radical Research. Boca Raton: CRC Press; 1985. p. 283-4.
15. Ohkawa H, Ohish N, Yogi K. Assay for lipid peroxidase in animal tissues by thiobarbituric acid. Anal Biochem 1979:95:351-8.
16. Antonio A , Jose M, Jose S, Rita F, Maria N, Franklim M, et al. Endurance training attenuates doxorubicin-induced cardiac oxidative damage in mice. Int J Cardiol 2005;100:451-60.
17. Hardina R, Gersl V, Klimtova I, Simunek T, Machackova J, Adamcova M. Anthracycline induced cardiotoxicity. Acta Med 2000;43:75-82.
18. Thippeswamy AH, Shirodkar A, Koti BC, Sadiq AJ, Praveen DM, Swamy AH, et al. Protective role of Phyllantusniruri extract in doxorubicin-induced myocardial toxicity in rats. Indain J Pharmacol 2011;43:31-5.
19. Koti BC, Vishwanathswamy AH, Wagawade J, Thippeswamy AH, Cardioprotective effect of lipistat against doxorubicin induced myocardial toxicity in albino rats. Indian J Exp Biol 2009;47:41-6.
20. Stroev EA, Makarova VG. Laboratory Manual in Biochemistry, Moscow: Mir Publishers; 1989. p. 154-6.
21. Kahn JC, Gueret P, Baudet M, Rocha P, Bardet J, Bourdarias JP. Clinical assessment of infarct size by serial determinations of serum creatine phosphokinase activity. Eur J Cardiol 1979;9:21-37
22. Hardina R, Gersl V, Klimtova I, Simunek T, Machackova J, Adamcova M. Anthracycline induced cardiotoxicity. Acta Medica 2000;43:75-82.
23. Takacs IE, Matkovics B, Varga SI, Homolay P, Feer G, Seres T, Study of the myocardial antioxidant defense in various species, Pharmacol Res1992;25:177-8.
24. Carr AC, Frei B. Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans Am J Clin Nutr 1999;69:1086-107.
25. Englard S, Seifter S. The biochemical functions of ascorbic acid. Annu Rev Nutr 1986;6:365-406.
26. Neuzil J, Thomas SR, Stocker R. Requirement for, promotion, or inhibition by alpha-tocopherol of radical-induced initiation of plasma lipoprotein lipid peroxidation. Free Radic Biol Med 1997;22:57-71.
27. Meister A. Glutathione-ascorbic acid antioxidant system in animals. J Biol Chem 1994;269:9397-400
28. Wu G, Fang YZ, Yang S, Lupton JR, Turner ND. Glutathione metabolism and its implications for health. J Nutr 2004;134:489-92.
29. Carnes CA, Chung MK, Nakayama T, Nakayama H, Baliga RS, Piao S, et al. Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ Res 2001;89:E32-8.
30. Mihm MJ, Yu F, Carnes CA, Reiser PJ, McCarthy PM, Van Wagoner DR, et al. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 2001;104:174-80.